Login / Signup

Predicting discontinuation of docetaxel treatment for metastatic castration-resistant prostate cancer (mCRPC) with random forest.

Daniel KristiyantoKevin E. AndersonLing-Hong HungKa Yee Yeung
Published in: F1000Research (2016)
Keyphrases